Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 30, 2017 - Issue 2
257
Views
6
CrossRef citations to date
0
Altmetric
Case Studies

Hemodialysis Failure Secondary to Hydroxocobalamin Exposure

  • Shepherd G, Velez LI. Role of hydroxocobalamin in acute cyanide poisoning. Ann Pharmacother 2008;42 (5): 661–669.
  • Chen KK, Rose CL. Nitrite and thiosulfate therapy in cyanide poisoning. J Am Med Assoc 1952;149 (2): 113–119.
  • Hall AH, Dart R, Bogdan G. Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning? Ann Emerg Med 2007;49 (6): 806–813.
  • Barillo DJ. Diagnosis and treatment of cyanide toxicity. J Burn Care Res 2009;30 (1): 148–152.
  • Hamel J. A review of acute cyanide poisoning with a treatment update. Crit Care Nurse 2011;31 (1): 72–81.
  • Uhl W, Nolting A, Golor G, Rost KL, Kovar A. Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study. Clin Toxicol (Phila) 2006;44 (Suppl 1): 17–28.
  • Curry SC, Connor DA, Raschke RA. Effect of the cyanide antidote hydroxocobalamin on commonly ordered serum chemistry studies. Ann Emerg Med 1994;24 (1): 65–67.
  • DesLauriers CA, Burda AM, Wahl M. Hydroxocobalamin as a cyanide antidote. Am J Ther 2006;13 (2): 161–165.
  • Pamidi PV, DeAbreu M, Kim D, Mansouri S. Hydroxocobalamin and cyanocobalamin interference on co-oximetry based hemoglobin measurements. Clin Chim Acta 2009;401 (1–2): 63–67.
  • Avila J, Prasad D, Weisberg LS, Kasama R. Pseudo-blood leak? A hemodialysis mystery. Clin Nephrol 2013;79 (4): 323–325.
  • Sutter M, Tereshchenko N, Rafii R, Daubert GP. Hemodialysis complications of hydroxocobalamin: a case report. J Med Toxicol 2010;6 (2): 165–167.
  • 2008K Hemodialysis Operator's Manual. Waltham, MA: Fresenius USA, 2014.
  • Sutter ME, Clarke ME, Cobb J, Daubert GP, Rathore VS, Aston LS, Poppenga RH, Ford JB, Owen KP, Albertson TE. Blood leak alarm interference by hydoxocobalamin is hemodialysis machine dependent. Clin Toxicol (Phila) 2012;50 (10): 892–895.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.